May 29, 2020
FiercePharma ranks the top 10 drug launches since 2017 by sales for their first four full quarters on the market. Drugs approved toward the end of […]
May 29, 2020
The FDA named 28 coronavirus antibody diagnostics it says should be taken off the market weeks after closing its open-door policy on COVID-19 blood tests and […]
May 29, 2020
Once valued at $4B, an embattled Akorn — nursing a market cap of roughly $37M — files for bankruptcy
Specialty generic drugmaker Akorn is filing for Chapter 11 weeks after giving up on finding itself a buyer amidst the Covid-19 pandemic. In the past few […]
May 31, 2020
June 12, 2020
Scientists, drugmakers and governments are moving with unprecedented speed to deliver a coronavirus vaccine in hopes of delivering one by the end of the year or […]
June 19, 2020
Neurocrine Biosciences has licensed seven psychiatry drug programs from Takeda in a deal valued at more than $2B, adding diversity to Neurocrine’s pipeline. Three of the […]
June 26, 2020
By Robert Ruth, Vice President & Managing Director, Ashton Tweed and Michelle E. Dickinson, Mental Health Strategist See this article on LinkedIn. “One in four people […]
July 3, 2020
Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies […]
July 10, 2020